Monitoring and evaluating disease management: Information requirements

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This paper addresses information essential to the creation, monitoring, and evaluation of disease management programs within managed-care organizations. Sound procedures for the collection and analysis of data are vital components of any effective disease management program. This presentation argues for a systemwide, rather than an atomistic, approach to data collection and analysis. Because every health system serves different populations, reliable demographic and health resource use data must be collected. Similarly, baseline data on physician prescribing behavior, patient compliance, and treatment costs are necessary to identify areas in need of improvement. Particular care must be taken to ensure that valid statistical models are developed to reflect the realities of the health system. The strengths and weaknesses of various internal and external data sources are discussed, with an emphasis on correlating and integrating information to provide comprehensive analyses of treatments and outcomes. The effects of different financial arrangements on data issues are also discussed, particularly in terms of contracting issues at successive stages in the development of a disease management program. This paper examines, in detail, data issues relating to monitoring prescribing behavior, modeling therapy interventions, classifying outcomes, and utilization of resources and treatments. Finally, this presentation makes specific recommendations for designing valid procedures for data collection and analysis.

Original languageEnglish (US)
Pages (from-to)1327-1333
Number of pages7
JournalClinical Therapeutics
Volume18
Issue number6
DOIs
StatePublished - 1996

Fingerprint

Disease Management
Behavior Therapy
Health Resources
Information Storage and Retrieval
Health
Managed Care Programs
Statistical Models
Patient Compliance
Health Care Costs
Demography
Organizations
Physicians
Population
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Monitoring and evaluating disease management : Information requirements. / Armstrong, Edward P.

In: Clinical Therapeutics, Vol. 18, No. 6, 1996, p. 1327-1333.

Research output: Contribution to journalArticle

@article{bc19fedbc48d4229ac0b8876ea130709,
title = "Monitoring and evaluating disease management: Information requirements",
abstract = "This paper addresses information essential to the creation, monitoring, and evaluation of disease management programs within managed-care organizations. Sound procedures for the collection and analysis of data are vital components of any effective disease management program. This presentation argues for a systemwide, rather than an atomistic, approach to data collection and analysis. Because every health system serves different populations, reliable demographic and health resource use data must be collected. Similarly, baseline data on physician prescribing behavior, patient compliance, and treatment costs are necessary to identify areas in need of improvement. Particular care must be taken to ensure that valid statistical models are developed to reflect the realities of the health system. The strengths and weaknesses of various internal and external data sources are discussed, with an emphasis on correlating and integrating information to provide comprehensive analyses of treatments and outcomes. The effects of different financial arrangements on data issues are also discussed, particularly in terms of contracting issues at successive stages in the development of a disease management program. This paper examines, in detail, data issues relating to monitoring prescribing behavior, modeling therapy interventions, classifying outcomes, and utilization of resources and treatments. Finally, this presentation makes specific recommendations for designing valid procedures for data collection and analysis.",
author = "Armstrong, {Edward P}",
year = "1996",
doi = "10.1016/S0149-2918(96)80087-7",
language = "English (US)",
volume = "18",
pages = "1327--1333",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "6",

}

TY - JOUR

T1 - Monitoring and evaluating disease management

T2 - Information requirements

AU - Armstrong, Edward P

PY - 1996

Y1 - 1996

N2 - This paper addresses information essential to the creation, monitoring, and evaluation of disease management programs within managed-care organizations. Sound procedures for the collection and analysis of data are vital components of any effective disease management program. This presentation argues for a systemwide, rather than an atomistic, approach to data collection and analysis. Because every health system serves different populations, reliable demographic and health resource use data must be collected. Similarly, baseline data on physician prescribing behavior, patient compliance, and treatment costs are necessary to identify areas in need of improvement. Particular care must be taken to ensure that valid statistical models are developed to reflect the realities of the health system. The strengths and weaknesses of various internal and external data sources are discussed, with an emphasis on correlating and integrating information to provide comprehensive analyses of treatments and outcomes. The effects of different financial arrangements on data issues are also discussed, particularly in terms of contracting issues at successive stages in the development of a disease management program. This paper examines, in detail, data issues relating to monitoring prescribing behavior, modeling therapy interventions, classifying outcomes, and utilization of resources and treatments. Finally, this presentation makes specific recommendations for designing valid procedures for data collection and analysis.

AB - This paper addresses information essential to the creation, monitoring, and evaluation of disease management programs within managed-care organizations. Sound procedures for the collection and analysis of data are vital components of any effective disease management program. This presentation argues for a systemwide, rather than an atomistic, approach to data collection and analysis. Because every health system serves different populations, reliable demographic and health resource use data must be collected. Similarly, baseline data on physician prescribing behavior, patient compliance, and treatment costs are necessary to identify areas in need of improvement. Particular care must be taken to ensure that valid statistical models are developed to reflect the realities of the health system. The strengths and weaknesses of various internal and external data sources are discussed, with an emphasis on correlating and integrating information to provide comprehensive analyses of treatments and outcomes. The effects of different financial arrangements on data issues are also discussed, particularly in terms of contracting issues at successive stages in the development of a disease management program. This paper examines, in detail, data issues relating to monitoring prescribing behavior, modeling therapy interventions, classifying outcomes, and utilization of resources and treatments. Finally, this presentation makes specific recommendations for designing valid procedures for data collection and analysis.

UR - http://www.scopus.com/inward/record.url?scp=0030497737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030497737&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(96)80087-7

DO - 10.1016/S0149-2918(96)80087-7

M3 - Article

C2 - 9001848

AN - SCOPUS:0030497737

VL - 18

SP - 1327

EP - 1333

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 6

ER -